Cass I - Search Results

1

Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.

Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ; Society of Gynecologic Oncologists Education Committee. Lancaster JM, et al. Among authors: cass i. Gynecol Oncol. 2007 Nov;107(2):159-62. doi: 10.1016/j.ygyno.2007.09.031. Gynecol Oncol. 2007. PMID: 17950381

2

Molecular advances in gynecologic oncology.

Cass I, Baldwin RL, Karlan BY. Cass I, et al. Curr Opin Oncol. 1999 Sep;11(5):394-400. doi: 10.1097/00001622-199909000-00013. Curr Opin Oncol. 1999. PMID: 10505778 Review.

3

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Among authors: cass i. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

4

Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.

Cass I, Li AJ, Runowicz CD, Fields AL, Goldberg GL, Leuchter RS, Lagasse LD, Karlan BY. Cass I, et al. Gynecol Oncol. 2001 Jan;80(1):56-61. doi: 10.1006/gyno.2000.6027. Gynecol Oncol. 2001. PMID: 11136570

5

Allelotype of papillary serous peritoneal carcinomas.

Cass I, Baldwin RL, Fasylova E, Fields AL, Klinger HP, Runowicz CD, Karlan BY. Cass I, et al. Gynecol Oncol. 2001 Jul;82(1):69-76. doi: 10.1006/gyno.2001.6176. Gynecol Oncol. 2001. PMID: 11426964

6

Improved survival in women with BRCA-associated ovarian carcinoma.

Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY. Cass I, et al. Cancer. 2003 May 1;97(9):2187-95. doi: 10.1002/cncr.11310. Cancer. 2003. PMID: 12712470 Free article.

7

The prognostic significance of thrombocytosis in epithelial ovarian carcinoma.

Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY. Li AJ, et al. Among authors: cass i. Gynecol Oncol. 2004 Jan;92(1):211-4. doi: 10.1016/j.ygyno.2003.09.002. Gynecol Oncol. 2004. PMID: 14751160

8

Coexisting ovarian malignancy in young women with endometrial cancer.

Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Walsh C, et al. Among authors: cass i. Obstet Gynecol. 2005 Oct;106(4):693-9. doi: 10.1097/01.AOG.0000172423.64995.6f. Obstet Gynecol. 2005. PMID: 16199623

9

BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?

Cass I, Holschneider C, Datta N, Barbuto D, Walts AE, Karlan BY. Cass I, et al. Obstet Gynecol. 2005 Dec;106(6):1327-34. doi: 10.1097/01.AOG.0000187892.78392.3f. Obstet Gynecol. 2005. PMID: 16319259

10

The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.

Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ. Lerner DL, et al. Among authors: cass i. Gynecol Oncol. 2007 Jan;104(1):91-4. doi: 10.1016/j.ygyno.2006.07.020. Epub 2006 Aug 24. Gynecol Oncol. 2007. PMID: 16934317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters